Hepatitis C virus (HCV) is an established cause of chronic liver disease worldwide. Owing to the advent of highly effective therapy, high age-group seroprevalence, and many estimated missed cases, HCV screening recommendations for Baby Boomers (those born between 1945 and 1965) shifted in 2012 from risk based to universal screening.1 Owing to widespread injection drug use, HCV epidemiology has changed considerably with increased cases of HCV nationwide in teenagers and young adults.2–4 Despite these major changes in epidemiology, risk-based HCV screening is still recommended for young adults.